These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11900875)

  • 41. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
    Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients.
    Kámory E; Kolacsek O; Ottó S; Csuka O
    Pathol Oncol Res; 2003; 9(4):236-41. PubMed ID: 14688830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
    Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
    Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors.
    Hatch SB; Lightfoot HM; Garwacki CP; Moore DT; Calvo BF; Woosley JT; Sciarrotta J; Funkhouser WK; Farber RA
    Clin Cancer Res; 2005 Mar; 11(6):2180-7. PubMed ID: 15788665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
    Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients.
    Spaepen M; Vankeirsbilck B; Van Opstal S; Tejpar S; Van Cutsem E; Geboes K; Legius E; Matthijs G
    Fam Cancer; 2006; 5(2):179-89. PubMed ID: 16736289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
    Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
    Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences.
    Fujiwara T; Stolker JM; Watanabe T; Rashid A; Longo P; Eshleman JR; Booker S; Lynch HT; Jass JR; Green JS; Kim H; Jen J; Vogelstein B; Hamilton SR
    Am J Pathol; 1998 Oct; 153(4):1063-78. PubMed ID: 9777938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms?
    Müller-Koch Y; Kopp R; Lohse P; Baretton G; Stoetzer A; Aust D; Daum J; Kerker B; Gross M; Dietmeier W; Holinski-Feder E
    Eur J Med Res; 2001 Nov; 6(11):473-82. PubMed ID: 11726306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours.
    Ghimenti C; Tannergård P; Wahlberg S; Liu T; Giulianotti PG; Mosca F; Fornaciari G; Bevilacqua G; Lindblom A; Caligo MA
    Br J Cancer; 1999 Apr; 80(1-2):11-6. PubMed ID: 10389971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extensive molecular screening for hereditary non-polyposis colorectal cancer.
    Dieumegard B; Grandjouan S; Sabourin JC; Le Bihan ML; Lefrère I; Bellefqih ; Pignon JP; Rougier P; Lasser P; Bénard J; Couturier D; Bressac-de Paillerets B
    Br J Cancer; 2000 Feb; 82(4):871-80. PubMed ID: 10732761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
    Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
    Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
    Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
    Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer.
    Benatti P; Roncucci L; Ganazzi D; Percesepe A; Di Gregorio C; Pedroni M; Borghi F; Sala E; Scarselli A; Menigatti M; Rossi G; Genuardi M; Viel A; Ponz De Leon M
    Int J Cancer; 2001 Sep; 95(5):323-8. PubMed ID: 11494233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden.
    Planck M; Koul A; Fernebro E; Borg A; Kristoffersson U; Olsson H; Wenngren E; Mangell P; Nilbert M
    Int J Cancer; 1999 Oct; 83(2):197-202. PubMed ID: 10471527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
    Catto JW; Xinarianos G; Burton JL; Meuth M; Hamdy FC
    Int J Cancer; 2003 Jul; 105(4):484-90. PubMed ID: 12712438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional alterations of human exonuclease 1 mutants identified in atypical hereditary nonpolyposis colorectal cancer syndrome.
    Sun X; Zheng L; Shen B
    Cancer Res; 2002 Nov; 62(21):6026-30. PubMed ID: 12414623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.